Jubilant Cadista Pharmaceuticals, Inc. recalls Meclizine Hydrochloride Tablets USP, 12.5 mg
The stated reason: Labeling: Label mix-up: Incorrect label placed on product.
Jubilant Cadista Pharmaceuticals, Inc. began a drug recall on March 08, 2022 whose reported distribution included Ohio. FDA
What the record shows
recalled Meclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count bottle), Rx only, Manufactured by: Jubilant Cadista Pharmace… beginning March 08, 2022, in a drug recall whose distribution included Ohio. Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled as PredniSONE Tablets. The tablets in the bottles are Meclizine Hydrochloride FDA graded it Class I — a reasonable probability that use will cause serious health consequences or death. Quantity affected: 12,174 bottles. The recall is listed as terminated. FDA
Context
By the numbers
- Date of record: March 08, 2022 FDA
- Recall number: D-0767-2022 FDA
- Recalls in this action: 1 FDA
- Recalling firm: Jubilant Cadista Pharmaceuticals, Inc. FDA
- Product: Meclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count bottle), Rx only… FDA
- Reason for recall: Labeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Tablets… FDA
Assembled mechanically from the source filing and The Lantern's own record database — no AI-written prose. Every figure above appears verbatim in the cited record, which is linked on this page. FDA
Sources
The source filing
| Recall number | D-0767-2022 |
|---|---|
| Recalls in this action | 1 |
| Recalling firm | Jubilant Cadista Pharmaceuticals, Inc. |
| Product | Meclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count bottle), Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD, 21801, NDC 59746-122-06 |
| Reason for recall | Labeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled as PredniSONE Tablets. The tablets in the bottles are Meclizine Hydrochloride |
| Classification | Class I — a reasonable probability that use will cause serious health consequences or death |
| Recall type | drug |
| Quantity | 12,174 bottles |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm initiated |
| Initiated | 20220308 |
| Reported | 20220406 |
| Distribution | Product was distributed in Arkansas, Florida, North Carolina, South Carolina and Ohio. |
| Firm location | Salisbury, MD, United States |
Published by U.S. Food and Drug Administration (openFDA). This is the agency's public filing as The Lantern received it, shown with its fields named in plain English.